Peixoto, A., Pinto, P., Guerra, J., Pinheiro, M., Santos, C., Pinto, C., . . . Teixeira, M. R. (2020). Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects. Front Oncol.
Chicago Style CitationPeixoto, Ana, et al. "Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects." Front Oncol 2020.
Cita MLAPeixoto, Ana, et al. "Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects." Front Oncol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.